CN
SEARCH
High quality 3D cell manufacturing expert
OK
News
Focusing on innovative 3D cell technology products and services
News
Homepage
/
Enterprise Development
/
November 2023

November 2023

(Summary description)The world's first stem cell-based new drug, utilizing the Cytoniche's 3D FloTrix® process, has been accepted by the China Drug Evaluation (CDE).

November 2023

(Summary description)The world's first stem cell-based new drug, utilizing the Cytoniche's 3D FloTrix® process, has been accepted by the China Drug Evaluation (CDE).

Information

The world's first stem cell-based new drug, utilizing the Cytoniche's 3D FloTrix® process, has been accepted by the China Drug Evaluation (CDE).

Scan the QR code to read on your phone

Previous: November 2023
Next: September 2023
Previous: November 2023
Next: September 2023

Latest News

Strategic Partnership: CytoNiche Biotech and OBiO Tech Unite to Revolutionize 3D Cell Manufacturing

2024-08-09

Major Milestone Announcement!

2024-06-30

New Product Launch | 3D FloTrix® vivaROCK Bioreactor Stystem

2024-03-27

Overseas Debut | Engaging with the World, CytoNiche Lights Up the Stage!

2024-03-25
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.
京ICP备18061910号 京公网安备 11010802037749号
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.
京ICP备18061910号 京公网安备 11010802037749号